Table 2 from First-in-Human Dose-Escalation Study of Fianlimab, an Antilymphocyte Activation Gene-3 Antibody, with Cemiplimab in Patients with Advanced MalignanciesNehal J. Lakhani,Kyriakos P. Papadopoulos,Melissa Lynne Johnson,Haeseong Park,Ding Wang, Timothy A. Yap,Afshin Dowlati,Robert G. Maki,Susanna Ulahannan,Filipa Lynce,Karen Kelly,Stephen Williamson,Jyoti Malhotra,Shuquan Chen, Ana Gonzalez Ortiz,Vladimir Jankovic,Anne Paccaly,Sheila Masinde,Jayakumar Mani,Israel Lowy,Giuseppe Gullo,Tasha Sims,Glenn Kroogcrossref（2024）引用 0|浏览1AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
